Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.

Although there was a slight trend for a higher seroconversion rate in patients who temporarily suspended the use of mycophenolate mofetil or mycophenolic acid, it remains a matter of speculation whether an increase of the sample size would have changed the results essentially.

also in 4,078 other papers